These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1022 related items for PubMed ID: 7594574

  • 1. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.
    Ellison CA, MacDonald GC, Rector ES, Gartner JG.
    J Immunol; 1995 Nov 01; 155(9):4189-98. PubMed ID: 7594574
    [Abstract] [Full Text] [Related]

  • 2. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
    Miyakawa R, Miyaji C, Watanabe H, Yokoyama H, Tsukada C, Asakura H, Abo T.
    Eur J Immunol; 2002 Sep 01; 32(9):2521-31. PubMed ID: 12207336
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Gamma delta T cells from influenza-infected mice develop a natural killer cell phenotype following culture.
    Eichelberger M, Doherty PC.
    Cell Immunol; 1994 Nov 01; 159(1):94-102. PubMed ID: 7954844
    [Abstract] [Full Text] [Related]

  • 7. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
    Dobashi H, Seki S, Habu Y, Ohkawa T, Takeshita S, Hiraide H, Sekine I.
    Hepatology; 1999 Aug 01; 30(2):430-6. PubMed ID: 10421651
    [Abstract] [Full Text] [Related]

  • 8. Th1 cytokines and NK cells participate in the development of murine syngeneic graft-versus-host disease.
    Flanagan DL, Jennings CD, Bryson JS.
    J Immunol; 1999 Aug 01; 163(3):1170-7. PubMed ID: 10415011
    [Abstract] [Full Text] [Related]

  • 9. Splenic NK1.1-negative, TCR alpha beta intermediate CD4+ T cells exist in naive NK1.1 allelic positive and negative mice, with the capacity to rapidly secrete large amounts of IL-4 and IFN-gamma upon primary TCR stimulation.
    Moodycliffe AM, Maiti S, Ullrich SE.
    J Immunol; 1999 May 01; 162(9):5156-63. PubMed ID: 10227987
    [Abstract] [Full Text] [Related]

  • 10. Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.
    Mannoor MK, Weerasinghe A, Halder RC, Reza S, Morshed M, Ariyasinghe A, Watanabe H, Sekikawa H, Abo T.
    Cell Immunol; 2001 Aug 01; 211(2):96-104. PubMed ID: 11591113
    [Abstract] [Full Text] [Related]

  • 11. Development of CD4-CD8- alpha beta TCR+NK1.1+ T lymphocytes: thymic selection by self antigen.
    Schulz RJ, Parkes A, Mizoguchi E, Bhan AK, Koyasu S.
    J Immunol; 1996 Nov 15; 157(10):4379-89. PubMed ID: 8906813
    [Abstract] [Full Text] [Related]

  • 12. TCR alpha beta+ anti-tumor cytolytic T lymphocytes express NKR-P1 whilethe anti-tumor activity of TCR gamma delta+ T lymphocytes is not correlated to NKR-P1 expression.
    Yrlid U, Petersson E, Dohlsten M, Hedlund G.
    Cell Immunol; 1996 Nov 01; 173(2):287-94. PubMed ID: 8912889
    [Abstract] [Full Text] [Related]

  • 13. IL-7 up-regulates IL-4 production by splenic NK1.1+ and NK1.1- MHC class I-like/CD1-dependent CD4+ T cells.
    Hameg A, Gouarin C, Gombert JM, Hong S, Van Kaer L, Bach JF, Herbelin A.
    J Immunol; 1999 Jun 15; 162(12):7067-74. PubMed ID: 10358149
    [Abstract] [Full Text] [Related]

  • 14. Phenotypic and functional analysis of murine CD3+,CD4-,CD8- TCR-gamma delta-expressing peripheral T cells.
    Cron RQ, Gajewski TF, Sharrow SO, Fitch FW, Matis LA, Bluestone JA.
    J Immunol; 1989 Jun 01; 142(11):3754-62. PubMed ID: 2523934
    [Abstract] [Full Text] [Related]

  • 15. Natural killer-like T cells develop in SJL mice despite genetically distinct defects in NK1.1 expression and in inducible interleukin-4 production.
    Beutner U, Launois P, Ohteki T, Louis JA, MacDonald HR.
    Eur J Immunol; 1997 Apr 01; 27(4):928-34. PubMed ID: 9130646
    [Abstract] [Full Text] [Related]

  • 16. Natural killer activity in (C57BL/6 X DBA/2)F1 hybrids undergoing acute and chronic graft-vs.-host reaction.
    Pattengale PK, Ramstedt U, Gidlund M, Orn A, Axberg I, Wigzell H.
    Eur J Immunol; 1983 Nov 01; 13(11):912-9. PubMed ID: 6641788
    [Abstract] [Full Text] [Related]

  • 17. Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations.
    Ghayur T, Seemayer TA, Lapp WS.
    Transplantation; 1987 Aug 01; 44(2):254-60. PubMed ID: 3498241
    [Abstract] [Full Text] [Related]

  • 18. Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells.
    Seo N, Tokura Y, Takigawa M, Egawa K.
    J Immunol; 1999 Jul 01; 163(1):242-9. PubMed ID: 10384122
    [Abstract] [Full Text] [Related]

  • 19. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS, Sharrow SO, Shearer GM.
    J Immunol; 1987 Sep 15; 139(6):1840-9. PubMed ID: 2957440
    [Abstract] [Full Text] [Related]

  • 20. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells.
    Sugie T, Kubota H, Sato M, Nakamura E, Imamura M, Minato N.
    J Immunol; 1996 Nov 01; 157(9):3925-35. PubMed ID: 8892624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.